Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial - PubMed (original) (raw)

Randomized Controlled Trial

doi: 10.1007/s00392-008-0681-6. Epub 2008 Jun 9.

Svetlana Apostolović, Simone Inkrot, Elvis Tahirović, Florian Krackhardt, Milan Pavlović, Biljana Putniković, Mitja Lainscak, Götz Gelbrich, Frank Edelmann, Rolf Wachter, Thomas Eschenhagen, Finn Waagstein, Ferenc Follath, Mathias Rauchhaus, Wilhelm Haverkamp, Karl-Josef Osterziel, Rainer Dietz; CIBIS-ELD Investigators, Subproject Multicenter Trials in the Competence Network Heart Failure

Collaborators, Affiliations

Randomized Controlled Trial

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

Hans-Dirk Düngen et al. Clin Res Cardiol. 2008 Sep.

Abstract

Background: Chronic heart failure (CHF) is a widespread disease with severe quality of life impairment and a poor prognosis. Beta-blockers are the mainstay of CHF therapy; yet they are under-prescribed and under-dosed in clinical practice. This is particularly evident in elderly patients, which may be due to a fear of side-effects or intolerance. Beta-blockers have further not been adequately tested in patients with diastolic CHF, which is particularly common in elderly patients. Finally, comparative data on the use of different beta-blockers in patients with CHF is scarce.

Aim: To compare the tolerance of bisoprolol and carvedilol in elderly patients with CHF.

Methods: CIBIS-ELD is an investigator-initiated, multi-centre, 1:1 randomised, double-blind, phase III trial comparing bisoprolol and carvedilol in patients >or=65 years with systolic or diastolic CHF. Recruitment started in April 2005 and is anticipated to be completed by April 2008 with at least 800 patients enrolled.

Perspective: This is the first large scale head to head beta-blockers trial in an elderly population with CHF. Besides determining which of two standard beta-blockers is best tolerated in elderly patients with systolic or diastolic CHF, we expect to gain further insight into the treatment of the particular population of patients with diastolic CHF.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Clin Res Cardiol. 2008 Apr;97(4):244-52 - PubMed
    1. Heart. 2002 Dec;88(6):611-4 - PubMed
    1. Eur Heart J. 1987 Sep;8 Suppl F:23-6 - PubMed
    1. Eur Heart J. 2003 Mar;24(5):464-74 - PubMed
    1. J Card Fail. 2003 Dec;9(6):429-43 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources